Brief: Salarius Pharmaceuticals Reports Q4 And Full Year 2022 Financial Results

Decoy Therapeutics

27/03/2023 13:59

March 27 (Reuters) - Salarius Pharmaceuticals Inc
 SLRX.O :
    * SALARIUS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR
2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * NET LOSS FOR THE FOURTH QUARTER OF 2022 WAS $6.4 MILLION,
OR
$2.83 PER SHARE

Source text for Eikon:  ID:nGNX9VH8GV 
Further company coverage:  SLRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))